• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

Fulvestrant - Ready to start its journey in the breast cancer adjuvant endocrine world?

MJ Piccart-Gebhart, SM Loi

European Journal of Cancer | ELSEVIER SCI LTD | Published : 2005

DOI: 10.1016/j.ejca.2004.09.019

University of Melbourne Researchers

Prof Sherene Loi's Profile Picture
Prof Sherene Loi Author

Citation metrics

4Scopus
3Web of Science
3Dimensions

Keywords

Ici-182,780
Resistance
Gene-Expression Patterns
Science & Technology
Life Sciences & Biomedicine
3211 Oncology and Carcinogenesis
Postmenopausal Women
Oncology
Antiestrogen
Randomized-Trial
Letrozole
32 Biomedical and Clinical Sciences
Anastrozole
Double-Blind
Tamoxifen Therapy

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224